These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19089452)

  • 1. Identification of genomic regions contributing to etoposide-induced cytotoxicity.
    Bleibel WK; Duan S; Huang RS; Kistner EO; Shukla SJ; Wu X; Badner JA; Dolan ME
    Hum Genet; 2009 Mar; 125(2):173-80. PubMed ID: 19089452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.
    Huang RS; Duan S; Bleibel WK; Kistner EO; Zhang W; Clark TA; Chen TX; Schweitzer AC; Blume JE; Cox NJ; Dolan ME
    Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9758-63. PubMed ID: 17537913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping genes that contribute to daunorubicin-induced cytotoxicity.
    Duan S; Bleibel WK; Huang RS; Shukla SJ; Wu X; Badner JA; Dolan ME
    Cancer Res; 2007 Jun; 67(11):5425-33. PubMed ID: 17545624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility loci involved in cisplatin-induced cytotoxicity and apoptosis.
    Shukla SJ; Duan S; Badner JA; Wu X; Dolan ME
    Pharmacogenet Genomics; 2008 Mar; 18(3):253-62. PubMed ID: 18300947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide discovery of loci influencing chemotherapy cytotoxicity.
    Watters JW; Kraja A; Meucci MA; Province MA; McLeod HL
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11809-14. PubMed ID: 15282376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity.
    Dolan ME; Newbold KG; Nagasubramanian R; Wu X; Ratain MJ; Cook EH; Badner JA
    Cancer Res; 2004 Jun; 64(12):4353-6. PubMed ID: 15205351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-genome approach implicates CD44 in cellular resistance to carboplatin.
    Shukla SJ; Duan S; Wu X; Badner JA; Kasza K; Dolan ME
    Hum Genomics; 2009 Jan; 3(2):128-42. PubMed ID: 19164090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between cytotoxicity and site-specific DNA recombination after in vitro exposure of leukemia cells to etoposide.
    Chen CL; Fuscoe JC; Liu Q; Pui CH; Mahmoud HH; Relling MV
    J Natl Cancer Inst; 1996 Dec; 88(24):1840-7. PubMed ID: 8961974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variants contributing to daunorubicin-induced cytotoxicity.
    Huang RS; Duan S; Kistner EO; Bleibel WK; Delaney SM; Fackenthal DL; Das S; Dolan ME
    Cancer Res; 2008 May; 68(9):3161-8. PubMed ID: 18451141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of CEPH and non-CEPH lymphoblast cell lines in pharmacogenetic studies.
    Shukla SJ; Dolan ME
    Pharmacogenomics; 2005 Apr; 6(3):303-10. PubMed ID: 16013961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of RAD21 gene expression decreases cell growth and enhances cytotoxicity of etoposide and bleomycin in human breast cancer cells.
    Atienza JM; Roth RB; Rosette C; Smylie KJ; Kammerer S; Rehbock J; Ekblom J; Denissenko MF
    Mol Cancer Ther; 2005 Mar; 4(3):361-8. PubMed ID: 15767545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of heritability in mapping expression quantitative trait loci.
    Huang S; Ballard D; Zhao H
    BMC Proc; 2007; 1 Suppl 1(Suppl 1):S86. PubMed ID: 18466589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of Mcl-1 by small interference RNA induces apoptosis and sensitizes HL-60 leukemia cells to etoposide.
    Karami H; Baradaran B; Esfehani A; Sakhinia M; Sakhinia E
    Asian Pac J Cancer Prev; 2014; 15(2):629-35. PubMed ID: 24568469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of p38 MAPK-dependent excision repair cross-complementing 1 expression decreases the DNA repair capacity to sensitize lung cancer cells to etoposide.
    Tsai MS; Weng SH; Chen HJ; Chiu YF; Huang YC; Tseng SC; Kuo YH; Lin YW
    Mol Cancer Ther; 2012 Mar; 11(3):561-71. PubMed ID: 22053010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling crosstalk of FHIT, CHK2 and p38 in etoposide induced growth inhibition in MCF-7 cells.
    Mir Mohammadrezaei F; Mohseni kouchesfehani H; Montazeri H; Gharghabi M; Ostad SN; Ghahremani MH
    Cell Signal; 2013 Jan; 25(1):126-32. PubMed ID: 23000346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.
    Stark AL; Zhang W; Mi S; Duan S; O'Donnell PH; Huang RS; Dolan ME
    Pharmacogenomics J; 2010 Dec; 10(6):505-12. PubMed ID: 20142840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically regulated expression underlies cellular sensitivity to chemotherapy in diverse populations.
    Mulford AJ; Wing C; Dolan ME; Wheeler HE
    Hum Mol Genet; 2021 Apr; 30(3-4):305-317. PubMed ID: 33575800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli.
    Chiche J; Rouleau M; Gounon P; Brahimi-Horn MC; Pouysségur J; Mazure NM
    J Cell Physiol; 2010 Mar; 222(3):648-57. PubMed ID: 19957303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IER3 is a crucial mediator of TAp73β-induced apoptosis in cervical cancer and confers etoposide sensitivity.
    Jin H; Suh DS; Kim TH; Yeom JH; Lee K; Bae J
    Sci Rep; 2015 Feb; 5():8367. PubMed ID: 25666857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Whole-genome sequencing identifies functional noncoding variation in SEMA3C that cosegregates with dyslexia in a multigenerational family.
    Carrion-Castillo A; Estruch SB; Maassen B; Franke B; Francks C; Fisher SE
    Hum Genet; 2021 Aug; 140(8):1183-1200. PubMed ID: 34076780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.